Novartis · 1 week ago
Radioligand Therapies (RLT) Associate Director, Priority Accounts – Salt Lake City
Novartis is a leading pharmaceutical company, and they are seeking a Radioligand Therapies (RLT) Associate Director for Priority Accounts. This role involves partnering with key healthcare systems to develop strategic business plans and enhance product utilization, requiring strong institutional selling skills and cross-functional collaboration.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Champion institutional advocacy for the adoption of the Radioligand Therapies (RLT) and Neuroendocrine Tumors (NET) brand to support appropriate product utilization
Build strong partnerships with Neuroendocrine Tumors Centers of Excellence and health care system sites to drive impactful engagement
Develop, coordinate, and execute strategic business plans for priority accounts, ensuring alignment with market dynamics and organizational goals
Cultivate relationships with clinical, operational, and administrative decision-makers to streamline care pathways, treatment protocols, and workflow solutions
Stay informed on market trends, customer economics, and access models, including payment programs and reimbursement strategies
Share knowledge of Novartis’ offerings and ensure account administrators have access to relevant resources, while maintaining compliance
Collaborate with local teams to create tailored, institution-specific plans that reflect local market forces and opportunities
Deliver approved product and disease state presentations to clinicians and staff, fostering trust and collaboration across key partners
Conduct periodic needs assessments to identify opportunities and communicate actionable insights to cross-functional partners
Support team members in diagnosing business challenges and implementing strategies that optimize outcomes for Radioligand Therapies and Neuroendocrine Tumors accounts and affiliated health systems
Qualification
Required
Bachelor's degree required from 4-year college or university
8+ years' experience in pharmaceutical, biotech, healthcare, or similarly structured industries with large, geographically dispersed field teams. We also welcome candidates from other complex sales environments such as medical devices, diagnostics, life sciences services, insurance, consumer health, or B2B sectors, especially where strong field leadership and customer engagement are central to success
2+ years' experience in project management and translation of strategy into execution
3+ years' experience managing complex accounts, including large academic centers and hospitals, with demonstrated success in strategic account management
Recent US experience (within last 5 years) with deep understanding of US healthcare ecosystems
Demonstrated deep customer and cross-functional knowledge, healthcare ecosystem thinking, with strong business acumen and technology/digital engagement proficiency
Robust business background, with strong ability to collaborate and work cross-functionally in a matrix environment to build effective strategic account plans aligned to customer and organization goals
Candidate must reside within territory or reside in a territory adjacent to the assigned geography. Ability to travel 60-80% over a broad geography is required, with the ability to drive and/or fly within the territory. Must have a valid driver's license
Preferred
Strong knowledge of the Radioligand Therapies (RLT) platform and experience representing Radioligand Therapies products, with a proven ability to drive adoption at scale
Cross-functional experience in areas such as Marketing, Medical, Market Access, Reimbursement, or Sales Leadership, and prior engagement with assigned accounts
Benefits
Health, life and disability benefits
A 401(k) with company contribution and match
A generous time off package including vacation, personal days, holidays and other leaves
Company
Novartis
Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives.
Funding
Current Stage
Public CompanyTotal Funding
$2.49BKey Investors
Bill & Melinda Gates Foundation
2024-06-19Post Ipo Debt· $2.49B
2018-02-14Grant· $6.5M
2000-05-19IPO
Leadership Team
Recent News
2026-01-08
2026-01-08
2026-01-07
Company data provided by crunchbase